Angiotensin II, III, and IV may be important in the progression of COVID-19

Documenti analoghi

• Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension
  di: Cure, Erkan, et al.
  Pubblicazione: (2020)
• Comment on “ACE inhibitors and COVID‐19: We don't know yet”
  di: Ilcol, Tevfik Bulent, et al.
  Pubblicazione: (2020)
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
  di: Cure, Erkan, et al.
  Pubblicazione: (2020)
• COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets
  di: Cure, Erkan, et al.
  Pubblicazione: (2020)
• Comment on ‘Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?’
  di: Cüre, Erkan, et al.
  Pubblicazione: (2020)